Managing locally recurrent renal cell carcinoma after partial or radical nephrectomy poses significant technical and therapeutic challenges for clinicians. The value of aggressive surgical resection in these cases is well recognized. Retrospective studies highlight the feasibility of salvage surgery and its potential benefits for oncologic outcomes. However, there are clear trade-offs between the possible oncologic advantages of surgical removal and the high-risk nature of salvage renal surgery. Similarly, diagnosing local recurrence after primary ablative therapy can be difficult with cross-sectional imaging, and salvage surgery in these cases is technically complex. Confirming local recurrence is essential before proceeding with surgical intervention. Metastatic disease introduces additional, unique challenges. Metastasectomy has shown promise in the management of these patients but should be approached with a full understanding of the surgical risks involved. Several retrospective studies have reported excellent survival outcomes in well-selected patients undergoing surgery for metastatic disease. Overall, careful patient selection and thorough risk assessment are crucial for successful surgical management of both locally recurrent and metastatic disease. As the use of targeted therapy and immunotherapy continues to advance, further evaluation of the timing and role of surgery will be necessary to establish effective standards of care.